Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Sales (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Return on Sales for 16 consecutive years, with 0.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 17.0% year-over-year to 0.11%, compared with a TTM value of 0.08% through Sep 2025, down 6.0%, and an annual FY2024 reading of 0.01%, up 10.0% over the prior year.
  • Return on Sales was 0.11% for Q3 2025 at Rockwell Medical, down from 0.1% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.06% in Q3 2024 and bottomed at 0.58% in Q4 2021.
  • Average Return on Sales over 5 years is 0.21%, with a median of 0.11% recorded in 2025.
  • The sharpest move saw Return on Sales dropped -17bps in 2021, then surged 46bps in 2022.
  • Year by year, Return on Sales stood at 0.58% in 2021, then skyrocketed by 79bps to 0.12% in 2022, then soared by 40bps to 0.07% in 2023, then surged by 57bps to 0.03% in 2024, then tumbled by -261bps to 0.11% in 2025.
  • Business Quant data shows Return on Sales for RMTI at 0.11% in Q3 2025, 0.1% in Q2 2025, and 0.08% in Q1 2025.